The table below shows Medtronic plc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q2 2025
Q2 2024
Q2 2023
Q2 2022
Q2 2021
Q2 2020
Operating cash flow
$1.09B
$986.00M
$875.00M
$1.08B
$1.29B
$278.00M
Capital expenditure
$504.00M
$520.00M
$354.00M
$426.00M
$378.00M
$334.00M
Investing cash flow
-$719.00M
-$259.00M
-$539.00M
-$1.58B
-$784.00M
$8.00M
Dividends paid
$910.00M
$898.00M
$918.00M
$903.00M
MDT operating cash flow (10-K history)
Medtronic plc reported operating cash flow of $7.04B for fiscal year 2025. That is up 3.8% from $6.79B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $5.22B (FY 2016) to $7.04B. Figures come from the company's audited annual reports as filed with the SEC.